Jiangsu gdk Biotechnology Co (SHSE:688670) EBITDA Margin % : -506.10% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Jiangsu gdk Biotechnology Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Jiangsu gdk Biotechnology Co's EBITDA for the three months ended in Mar. 2024 was ¥-25.40 Mil. Jiangsu gdk Biotechnology Co's Revenue for the three months ended in Mar. 2024 was ¥5.02 Mil. Therefore, Jiangsu gdk Biotechnology Co's EBITDA margin for the quarter that ended in Mar. 2024 was -506.10%.

Jiangsu gdk Biotechnology Co EBITDA Margin % Historical Data

The historical data trend for Jiangsu gdk Biotechnology Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu gdk Biotechnology Co EBITDA Margin % Chart

Jiangsu gdk Biotechnology Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

-7.42

41.82

31.08

24.95

-40.72

Jiangsu gdk Biotechnology Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBITDA Margin %	Get a 7-Day Free Trial															38.77	-1.05	903.19	-500.01	-506.10

Competitive Comparison of Jiangsu gdk Biotechnology Co's EBITDA Margin %

For the Biotechnology subindustry, Jiangsu gdk Biotechnology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu gdk Biotechnology Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu gdk Biotechnology Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Jiangsu gdk Biotechnology Co's EBITDA Margin % falls into.

Jiangsu gdk Biotechnology Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Jiangsu gdk Biotechnology Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-54.803	/	134.591
	=	-40.72 %

Jiangsu gdk Biotechnology Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-25.396	/	5.018
	=	-506.10 %

Jiangsu gdk Biotechnology Co (SHSE:688670) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Jiangsu gdk Biotechnology Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Jiangsu gdk Biotechnology Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu gdk Biotechnology Co (SHSE:688670) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu gdk Biotechnology Co Ltd (SHSE:688670) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12 Yujin Road, Jiangsu Province, Taizhou, CHN, 225300

Website

http://www.gdkbio.com

Jiangsu gdk Biotechnology Co Ltd is a biological high-tech enterprise integrating scientific research, production, operation and service of human vaccines. The company's product pipeline covers prevention of five important infectious diseases such as influenza, rabies, chickenpox, shingles and pneumonia.

Jiangsu gdk Biotechnology Co (SHSE:688670) Headlines

No Headlines